https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34542 Tue 26 Mar 2019 15:11:01 AEDT ]]> Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49703 Mon 29 May 2023 13:00:52 AEST ]]>